PrimeRFP SCOUT · Federal Contract Profile

Cytopath Biopsy Lab (KC5VWAGMNLT6)Federal contracts · 6 recompetes

Cytopath Biopsy Lab holds $5.9M in federal volume across 72 award actions, with 101% at Department of Veterans Affairs (VA). SCOUT tracks 6 incumbent recompetes — an estimated $1.1M returning to market over the next 24 months (High exposure). Primary work: Medical Laboratories; Testing Laboratories (100% prime). Obligations are down 17% year over year.

$5.9M

Federal Volume

Recompetes (24mo)

Top Agency · 101% firm-wide

72

Award Actions

Choose one — this changes what we ask next

Score my firm against Cytopath Biopsy Lab

Email me when a Cytopath Biopsy Lab recompete window opens.

Data through August 2026 · refreshed monthly · window Aug 2025 – Aug 2026

What they do

Capability

Service lines

MEDICAL LABORATORIES · TESTING LABORATORIES · TESTING LABORATORIES AND SERVICES

Work mix: 100% prime · 0% sub · primary NAICS 621511 / PSC Q301 REFERENCE LABORATORY TESTING

Where they win

Sole agency

Sole agency: Department of Veterans Affairs (VA)

Department of Veterans Affairs (VA)$5.9M · 100% of firm total

Recompete exposure: High · 6 in 24mo

Cytopath Biopsy Lab has an estimated $1.1M in contracts returning to market over the next 24 months.

Part of the CYTOPATH BIOPSY LAB INC corporate family · 7 entities

Metrics basis: local_db_api_validated

Who buys from them

Agency buyer map

1 buyers

Department of Veterans Affairs (VA)140 awards · repeat buyer · $5.9M

Recompete exposure & trajectory

Recompete exposure

High

Cytopath Biopsy Lab has an estimated $1.1M in contracts returning to market over the next 24 months. 4 within 6 months ($666K).

INCREASE RMR MOLECULAR THYROID REFERENCE TESTING CALL ORDER TO FUND YEAR 5 →

PIID: 36C25925N0290 · Expires 2026-09-24

$120K

THYROID TESTING LAB SERVICE →

PIID: 36C24125N0751 · Expires 2026-09-29

$300K

THYROSEQ →

PIID: 36C24626N0170 · Expires 2026-09-30

$100K

THYROSEQ V3 GENOMIC CLASSIFIER (GC) TESTING →

PIID: 36C25026P0252 · Expires 2026-12-28

$146K

THYROSEQUENCE TESTING SERVICE →

PIID: 36C24223N0352 · Expires 2028-02-12

$360K

THYROSEQUENCE TESTING SERVICE →

PIID: 36C24225N0344 · Expires 2028-02-12

$120K

Trajectory

▼ Consolidating-17% YoYFY2025 vs FY2024

'23

'24

'25

“With competitive federal procurements, winning starts with strategically understanding the customer environment to the left of SAM.gov. This is what SCOUT does - a deeper and more precise understanding of what the…”

— Peter Lierni, Solutioneering

Explore another company

Don’t see your company?

Enter your company name and we'll build the page.

Query this company live in SCOUT via MCP — personalized displacement scoring, alerts, and capture workflow. Learn about SCOUT MCP →

Frequently asked questions

What federal contracts does Cytopath Biopsy Lab hold?

Cytopath Biopsy Lab (UEI KC5VWAGMNLT6) shows $5.9M across 72 award actions in SCOUT’s public USASpending-backed profile, with Department of Veterans Affairs (VA) as the top buying agency. Totals cover federal prime awards ≥$100K in the rolling window.

How much in federal contracts does Cytopath Biopsy Lab have?

Cytopath Biopsy Lab shows $5.9M across 72 award actions. SCOUT tracks 6 incumbent recompetes ($1.1M) returning to market in the next 24 months.

Which agencies does Cytopath Biopsy Lab work with?

Cytopath Biopsy Lab’s firm-wide obligated mix is led by Department of Veterans Affairs (VA) (101%).

What is the UEI for Cytopath Biopsy Lab?

The Unique Entity ID (UEI) for Cytopath Biopsy Lab is KC5VWAGMNLT6.

Does Cytopath Biopsy Lab have contracts coming up for recompete?

Yes — SCOUT tracks 6 incumbent recompetes in the next 24 months (High exposure). Open the recompete section on this page for PIID-level timing.

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.